Rothberg Michael B, Haessler Sarah, Lagu Tara, Lindenauer Peter K, Pekow Penelope S, Priya Aruna, Skiest Daniel, Zilberberg Marya D
Center for Value-Based Care Research, Medicine Institute, Cleveland Clinic, Cleveland, Ohio.
Infect Control Hosp Epidemiol. 2014 Oct;35 Suppl 3(0 3):S107-15. doi: 10.1086/677829.
Healthcare-associated pneumonia (HCAP) is an entity distinct from community-acquired pneumonia (CAP). HCAP has a higher case-fatality rate, due either to HCAP organisms or to the health status of HCAP patients. The contribution of HCAP criteria to case-fatality rate is unknown.
We conducted a retrospective review of adult patients admitted with a diagnosis of pneumonia from July 2007 through November 2011 to 491 US hospitals. HCAP was defined as having at least 1 of the following: prior hospitalization within 90 days, hemodialysis, admission from a skilled nursing facility, or immune suppression. We compared characteristics of patients with CAP and patients with HCAP and explored the contribution of HCAP criteria to case-fatality rate in a hierarchical generalized linear model.
Of 436,483 patients hospitalized with pneumonia, 149,963 (34.4%) had HCAP. Compared to CAP patients, HCAP patients were older, had more comorbidities, and were more likely to require intensive care unit (ICU) care. In-hospital case-fatality rate was higher among patients with HCAP, compared to those with CAP (11.1% vs 5.1%, P < .001). After adjustment for demographics, comorbidities, presence of other infections, early ICU admission, chronic and acute medications, early tests and therapies, and length of stay, HCAP remained associated with increased case-fatality rate (odds ratio [OR], 1.35 [95% confidence interval (CI), 1.32-1.39]); odds of death increased for each additional HCAP criterion (OR [95% CI]: 1 criterion, 1.27 [1.23-1.31], 2 criteria, 1.55 [1.49-1.62], and 3 or more criteria, 1.88 [1.72-2.06]).
After adjustment for differences in patient characteristics, HCAP was associated with greater case-fatality rate than CAP. This difference may be due to HCAP organisms or to HCAP criteria themselves.
医疗保健相关肺炎(HCAP)是一种有别于社区获得性肺炎(CAP)的疾病。HCAP的病死率较高,这可能是由HCAP病原体或HCAP患者的健康状况所致。HCAP诊断标准对病死率的影响尚不清楚。
我们对2007年7月至2011年11月间美国491家医院收治的诊断为肺炎的成年患者进行了一项回顾性研究。HCAP定义为具备以下至少一项:90天内曾住院治疗、接受血液透析、从专业护理机构入院或存在免疫抑制。我们比较了CAP患者和HCAP患者的特征,并在分层广义线性模型中探讨了HCAP诊断标准对病死率的影响。
在436,483例因肺炎住院的患者中,149,963例(34.4%)为HCAP。与CAP患者相比,HCAP患者年龄更大,合并症更多,且更有可能需要入住重症监护病房(ICU)。HCAP患者的院内病死率高于CAP患者(11.1%对5.1%,P <.001)。在对人口统计学、合并症、其他感染的存在情况、早期入住ICU、慢性和急性用药情况、早期检查和治疗以及住院时间进行调整后,HCAP仍然与病死率增加相关(比值比[OR],1.35[95%置信区间(CI),1.32 - 1.39]);每增加一项HCAP诊断标准,死亡几率就会增加(OR[95%CI]:一项标准,1.27[1.23 - 1.31];两项标准,1.55[1.49 - 1.62];三项或更多标准,1.88[1.72 - 2.06])。
在对患者特征差异进行调整后,HCAP的病死率高于CAP。这种差异可能是由HCAP病原体或HCAP诊断标准本身导致的。